✦ LIBER ✦

Effects of long-term treatment with 120 mg of sustained-release isosorbide dinitrate and 60 mg of sustained-release nifedipine on myocardial perfusion

✍ Scribed by Beatrice Stegaru; Reinhard Loose; Helmut Keller; Jan Buss; Eduard Wetzel

Book ID: 113115015
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 394 KB
Volume: 61
Category: Article
ISSN: 0002-9149
DOI: 10.1016/0002-9149(88)90094-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiischemic effects of a newly develope

Antiischemic effects of a newly developed capsule containing 120 mg isosorbide dinitrate in sustained release form

✍ Sigmund Silber; Astrid C. Vogler; Franz Spiegelsberger; Margot Vogel; Karl Theis 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Sustained-release isosorbide mononitrate

Sustained-release isosorbide mononitrate (50 mg): Optimization of a once-daily dosage form for long-term treatment of angina pectoris

✍ Rainer Bonn 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Comparison of 50-mg and 100-mg sustained

Comparison of 50-mg and 100-mg sustained-release isosorbide mononitrate in the treatment of stable angina pectoris: effects on quality-of-life indices

✍ Aeilko H. Zwinderman; Ton J.M. Cleophas; Menco G. Niemeyer; Ernst E. Van Der Wal 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 649 KB

One-year treatment with standard and sus

One-year treatment with standard and sustained-release levodopa: Appropriate long-term treatment of restless legs syndrome?

✍ Claudia Trenkwalder; Victor Collado Seidel; Jörg Kazenwadel; Thomas C. Wetter; W 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

## Abstract To investigate the long‐term efficacy and safety of sustained‐release (SR) in combination with regular‐release (RR) levodopa/benserazide in the treatment of restless legs syndrome (RLS), an open‐label, prospective, extension study of a preceding double‐blind crossover trial was performe